The United States is actively encouraging collaboration between American and Indonesian pharmaceutical companies to foster a more inclusive healthcare system in Indonesia. This initiative was highlighted during a meeting held on October 22, 2024, where U.S. Ambassador to Indonesia, Kamala Shirin Lakhdhir, engaged with representatives from both American and Indonesian pharmaceutical firms to discuss innovative healthcare solutions and therapies tailored for the Indonesian population.

This partnership aims to bridge public and private sectors, enhancing health outcomes in Indonesia and striving toward a more inclusive healthcare system. The American pharmaceutical companies currently operating in Indonesia face various challenges, such as complex and frequently changing regulations, lengthy approval processes, and local content requirements that can drive up costs and complicate supply chains.

Jamie Ravetz, a spokesperson for the U.S. Embassy, emphasized the importance of these pharmaceutical companies, stating that they play a vital role in advancing the healthcare sector by providing innovative solutions. The U.S. is keen on ensuring better access to high-quality healthcare services for the Indonesian population. This year marks the 75th anniversary of diplomatic relations between the U.S. and Indonesia, making this partnership even more significant as the two nations strengthen their comprehensive strategic partnership.

The U.S. hopes to work closely with Indonesia's new government to support economic growth and attract more foreign direct investment from the private sector. Over the decades, the U.S. has collaborated with Indonesia to enhance its healthcare system and achieve shared priorities. The U.S. Agency for International Development (USAID) has been instrumental in responding to public health crises and humanitarian needs, including the COVID-19 pandemic, in partnership with the Indonesian government, private sector, civil society, and other donors.

This ongoing collaboration highlights the U.S.'s commitment to supporting Indonesia's health sector and ensuring that its growth benefits all Indonesians. By facilitating dialogue and partnerships within the pharmaceutical industry, the U.S. aims to contribute to a healthier future for Indonesia.